Dongsheng Ouyang

1.8k total citations
59 papers, 1.3k citations indexed

About

Dongsheng Ouyang is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Dongsheng Ouyang has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Pharmacology and 12 papers in Pharmacology. Recurrent topics in Dongsheng Ouyang's work include Pharmacogenetics and Drug Metabolism (14 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Dongsheng Ouyang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Dongsheng Ouyang collaborates with scholars based in China, United States and Macao. Dongsheng Ouyang's co-authors include Xiangchang Zeng, Xiaoping Chen, Zhi‐Rong Tan, Fei Guo, Hong‐Hao Zhou, Hong‐Hao Zhou, Song‐Lin Huang, Tai Rao, Chaopeng Li and Hong‐Hao Zhou and has published in prestigious journals such as Hepatology, Scientific Reports and Molecules.

In The Last Decade

Dongsheng Ouyang

58 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongsheng Ouyang China 24 492 459 186 181 160 59 1.3k
Guo Yu China 23 177 0.4× 577 1.3× 200 1.1× 115 0.6× 128 0.8× 97 1.5k
Jukka Mäenpää Finland 26 624 1.3× 437 1.0× 285 1.5× 147 0.8× 91 0.6× 79 2.2k
Hong‐Guang Xie China 20 612 1.2× 402 0.9× 276 1.5× 334 1.8× 49 0.3× 63 1.6k
Xiaomei Fan China 19 512 1.0× 598 1.3× 249 1.3× 72 0.4× 70 0.4× 52 1.3k
Rong Shi China 20 337 0.7× 494 1.1× 202 1.1× 249 1.4× 156 1.0× 68 1.3k
Emad H. M. Hassanein Egypt 26 289 0.6× 566 1.2× 107 0.6× 147 0.8× 131 0.8× 71 1.6k
Marcella Martignoni Italy 12 684 1.4× 546 1.2× 646 3.5× 142 0.8× 59 0.4× 22 1.8k
Tatsuya Matsura Japan 27 278 0.6× 824 1.8× 129 0.7× 103 0.6× 117 0.7× 71 2.0k
Chengliang Zhang China 21 202 0.4× 425 0.9× 307 1.7× 274 1.5× 85 0.5× 77 1.4k
Jung‐Ran Noh South Korea 24 298 0.6× 652 1.4× 82 0.4× 94 0.5× 95 0.6× 58 1.4k

Countries citing papers authored by Dongsheng Ouyang

Since Specialization
Citations

This map shows the geographic impact of Dongsheng Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongsheng Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongsheng Ouyang more than expected).

Fields of papers citing papers by Dongsheng Ouyang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongsheng Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongsheng Ouyang. The network helps show where Dongsheng Ouyang may publish in the future.

Co-authorship network of co-authors of Dongsheng Ouyang

This figure shows the co-authorship network connecting the top 25 collaborators of Dongsheng Ouyang. A scholar is included among the top collaborators of Dongsheng Ouyang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongsheng Ouyang. Dongsheng Ouyang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Ding Wen, Yi Le, Zheng Qin Yin, et al.. (2025). Engineered nanovesicles targeting SERPINE1 overcome temozolomide resistance in glioblastoma. Cellular Signalling. 132. 111763–111763.
2.
Li, Xiaolu, et al.. (2024). Interfacial engineering in SnO2-embedded graphene anode materials for high performance lithium-ion batteries. Scientific Reports. 14(1). 16751–16751. 8 indexed citations
3.
Chen, Hong‐Ying, Kun Liu, Chong Ma, et al.. (2023). Qing-Kai-Ling oral liquid alleviated pneumonia via regulation of intestinal flora and metabolites in rats. Frontiers in Microbiology. 14. 1194401–1194401. 4 indexed citations
4.
Huang, Qi, et al.. (2021). Isoeucommin A attenuates kidney injury in diabetic nephropathy through the Nrf2/HO‐1 pathway. FEBS Open Bio. 11(8). 2350–2363. 13 indexed citations
5.
Rao, Tai, Luping Zhou, Xiangchang Zeng, et al.. (2020). Leucovorin ameliorated methotrexate induced intestinal toxicity via modulation of the gut microbiota. Toxicology and Applied Pharmacology. 391. 114900–114900. 32 indexed citations
6.
Zeng, Xiangchang, Fei Guo, & Dongsheng Ouyang. (2019). A review of the pharmacology and toxicology of aucubin. Fitoterapia. 140. 104443–104443. 84 indexed citations
7.
Yu, Jing, Lihua Zhang, Zhiying Luo, et al.. (2018). Relationship between polymorphisms of the lipid metabolism-related gene PLA2G16 and risk of colorectal cancer in the Chinese population. Functional & Integrative Genomics. 19(2). 227–236. 3 indexed citations
8.
Huang, Qi, Qiong Liu, & Dongsheng Ouyang. (2018). Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications. Medicinal Chemistry. 15(1). 3–7. 24 indexed citations
9.
Han, Feng, Weihua Huang, Yingying Tian, et al.. (2017). Aucubin and its hydrolytic derivative attenuate activation of hepatic stellate cells via modulation of TGF-β stimulation. Environmental Toxicology and Pharmacology. 50. 234–239. 23 indexed citations
10.
Xian, Jing, Weihua Huang, Yongjun Tang, et al.. (2015). Eucommia ulmoidesOliv. (Du-Zhong) Lignans Inhibit Angiotensin II-Stimulated Proliferation by Affecting P21, P27, and Bax Expression in Rat Mesangial Cells. Evidence-based Complementary and Alternative Medicine. 2015. 1–8. 10 indexed citations
11.
Li, Zhenyu, Xiaolan Deng, Weihua Huang, et al.. (2014). Lignans from the bark of Eucommia ulmoides inhibited Ang II-stimulated extracellular matrix biosynthesis in mesangial cells. Chinese Medicine. 9(1). 8–8. 23 indexed citations
12.
Li, Hui, Jing Xian, Xiaolan Deng, & Dongsheng Ouyang. (2013). [Targets of anti-hyperlipidemia drugs].. PubMed. 38(1). 101–8. 2 indexed citations
13.
Li, Ling, Zhenyu Li, Yan Jin, et al.. (2012). Racial difference in aldose reductase C-106T genetic polymorphism and association with essential hypertension.. PubMed. 37(2). 156–60. 2 indexed citations
14.
Gu, Juan, et al.. (2010). [Research progress in aldose reductase].. PubMed. 35(4). 395–400. 7 indexed citations
15.
Chen, Yao, Peng Xiao, Dongsheng Ouyang, et al.. (2009). SIMULTANEOUS ACTION OF THE FLAVONOID QUERCETIN ON CYTOCHROME P450 (CYP) 1A2, CYP2A6, N‐ACETYLTRANSFERASE AND XANTHINE OXIDASE ACTIVITY IN HEALTHY VOLUNTEERS. Clinical and Experimental Pharmacology and Physiology. 36(8). 828–833. 56 indexed citations
16.
Liu, Yingzi, Beisha Tang, Xinxiang Yan, et al.. (2009). Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson’s disease patients. European Journal of Clinical Pharmacology. 65(7). 679–683. 55 indexed citations
17.
Liu, Zhaoqian, Jie Liu, Wei Mo, et al.. (2006). Distributive characteristics of Ser49Gly and Gly389Arg genetic polymorphisms of beta1-adrenoceptor in Chinese Han and Dai populations1. Acta Pharmacologica Sinica. 27(2). 254–258. 8 indexed citations
18.
Luo, Chen‐Hui, An Wang, Ronghua Zhu, et al.. (2005). Gender specific association of CYP2C9*3 with hyperlipidaemia in Chinese. British Journal of Clinical Pharmacology. 60(6). 629–631. 3 indexed citations
19.
Zhu, Bing, Zhaoqian Liu, Guo‐Lin Chen, et al.. (2003). The distribution and gender difference of CYP3A activity in Chinese subjects. British Journal of Clinical Pharmacology. 55(3). 264–269. 63 indexed citations
20.
Shu, Yan, Zeneng Cheng, Zhaoqian Liu, et al.. (2001). Interindividual variations in levels and activities of cytochrome P-450 in liver microsomes of Chinese subjects.. PubMed. 22(3). 283–8. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guo Yu Breakdown of academic impact, for papers by Jukka Mäenpää Breakdown of academic impact, for papers by Hong‐Guang Xie Breakdown of academic impact, for papers by Xiaomei Fan Breakdown of academic impact, for papers by Rong Shi Breakdown of academic impact, for papers by Emad H. M. Hassanein Breakdown of academic impact, for papers by Marcella Martignoni Breakdown of academic impact, for papers by Tatsuya Matsura Breakdown of academic impact, for papers by Chengliang Zhang Breakdown of academic impact, for papers by Jung‐Ran Noh
Rankless by CCL
2026